Alinity c Total Bile Acids Reagent Kit - Indonesia BPOM Medical Device Registration
Alinity c Total Bile Acids Reagent Kit is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20101222082. The device is manufactured by SENTINEL CH. S.P.A. from Italy, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is ABBOTT PRODUCTS INDONESIA.
This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
Risk Classification
Product Class
Kelas : 2
Manufacturer
SENTINEL CH. S.P.A.Country of Origin
Italy
Authorized Representative
ABBOTT PRODUCTS INDONESIAAR Address
WISMA PONDOK INDAH 2 SUITE 1000, JL. SULTAN ISKANDAR MUDA KAV. V-TA
Registration Date
Nov 25, 2022
Expiry Date
Jul 19, 2027
Product Type
Clinical Chemistry Test System
Cholylglycine test system (kit & cair)
Invitro Diagnostics
ALINITY c Lithium Reagent Kit
SENTINEL Syphilis TP Cal Set
SENTINEL Syphilis TP Latex
Alinity c Total Bile Acids Calibrator Kit
ALINITY c CK-MB Reagent Kit
ALINITY c CRP Vario Wide Range Calibrator Kit
ALINITY c UIBC Reagent Kit
ALINITY c CK-MB Calibrator Kit
ALINITY c Iron Reagent Kit
ALINITY c CK-MB Control Kit
ARCHITECT Estradiol Reagent Kit
ABBOTT IRELAND DIAGNOSTICS DIVISION.
ARMADA 35 PTA Catheter
ABBOTT VASCULAR COSTA RICA
ARCHITECT PIVKA-II Controls
DENKA CO., LTD.
ARCHITECT PIVKA-II Reagent Kit
DENKA CO., LTD.
ALINITY i PIVKA-II Controls
DENKA CO., LTD.
ALINITY i PIVKA-II Calibrators
DENKA CO., LTD.
XIENCE Xpedition 48 Everolimus Eluting Coronary Stent System
ABBOTT VASCULAR
ALINITY c Calcium2
ABBOTT IRELAND DIAGNOSTICS DIVISION
HI-TORQUE Command 18 LT Guide Wire
ABBOTT VASCULAR
ARCHITECT BNP Controls
FUJIREBIO DIAGNOSTICS, INC.